NASDAQ:LIMN

LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News

LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News

Liminatus Pharma agreed to acquire InnocsAI in an all-stock deal, issuing 1.6 billion shares at $0.20 each—over 35 times its current share count. LIMN rose 51% to $0.2844 in premarket trading. The deal would add CAR-T cancer therapy assets, including a candidate authorized for a Phase 1/2a study in South Korea. Liminatus reported $1.91 million in cash and warned of “substantial doubt” about its ability to continue.
May 21, 2026

Stock Market Today

  • CBA vs Macquarie Shares: Choosing the Best ASX Financial Stock
    May 29, 2026, 8:54 PM EDT. Commonwealth Bank of Australia (CBA) and Macquarie Group Ltd (MQG) are two top ASX financial shares with distinct investment profiles. CBA offers stability, scale, and fully franked dividends, benefiting from its dominant position in Australian banking. It appeals to those seeking dependable income and resilience. However, CBA trades at a premium, reflecting its quality. Meanwhile, Macquarie is a global diversified financial group with interests in asset management, infrastructure, commodities, and energy transition. Its earnings are more variable, influenced by market conditions and deal flow, but it offers greater long-term growth potential by adapting to evolving global trends. Investors must weigh CBA's consistent returns against Macquarie's growth flexibility in today's market.